Jiazhou Ye, M.D., is a Professor of Hepatobiliary Surgery at the Guangxi Medical University Cancer Hospital, China (also known as the Guangxi Tumor Institute/Guangxi Cancer Center, China). He has been awarded multiple Chinese national science grants for liver cancer research projects. He serves as the chief secretary of the Integrated Prevention and Screening Committee for Liver Cancer under the China Anti-Cancer Association. With over 40 publications as first or corresponding author, his work has been cited by the European Association for the Study of the Liver (EASL) Clinical Practice Guidelines and four other clinical guidelines or expert consensuses on HCC (hepatocellular carcinoma) management.